Literature DB >> 19141982

[Toronto clinical scoring system in diabetic peripheral neuropathy].

Feng Liu1, Ji-Ping Mao, Xiang Yan.   

Abstract

OBJECTIVE: To evaluate the application value of Toronto clinical scoring system (TCSS) and its grading of neuropathy for diabetic peripheral neuropathy (DPN), and to explore the relationship between TCSS grading of neuropathy and the grading of diabetic nephropathy and diabetic retinopathy.
METHODS: A total of 209 patients of Type 2 diabtes (T2DM) underwent TCSS. Taking electrophysiological examination as a gold standard for diagnosing DPN, We compared the results of TCSS score > or = 6 with electrophysiological examination, and tried to select the optimal cut-off points of TCSS.
RESULTS: The corresponding accuracy, sensitivity, and specificity of TCSS score > or = 6 were 76.6%, 77.2%, and 75.6%, respectively.The Youden index and Kappa were 0.53 and 0.52, which implied TCSS score > or = 6 had a moderate consistency with electrophysiological examination. There was a linear positive correlation between TCSS grading of neuropathy and the grading of diabetic nephropathy and diabetic retinopathy (P<0.05). The optimal cut-off point was 5 or 6 among these patients.
CONCLUSION: TCSS is reliable in diagnosing DPN and its grading of neuropathy has clinical value.

Entities:  

Mesh:

Year:  2008        PMID: 19141982

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  4 in total

Review 1.  Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.

Authors:  Luis Miguel Román-Pintos; Geannyne Villegas-Rivera; Adolfo Daniel Rodríguez-Carrizalez; Alejandra Guillermina Miranda-Díaz; Ernesto Germán Cardona-Muñoz
Journal:  J Diabetes Res       Date:  2016-12-12       Impact factor: 4.011

Review 2.  Gold Standard for Diagnosis of DPN.

Authors:  Yongchun Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-26       Impact factor: 5.555

3.  Herbal medicine foot bath for the treatment of diabetic peripheral neuropathy: protocol for a randomized, double-blind and controlled trial.

Authors:  Guanjie Fan; Haoyue Huang; Yuping Lin; Guoqing Zheng; Xianyu Tang; Yu Fu; Hua Wei; Ling Zhao; Zhenjie Liu; Mei Wang; Shidong Wang; Qingbo Li; Zhaohui Fang; Yuehong Zhou; Fang Dai; Xiaotang Qiu
Journal:  Trials       Date:  2018-09-10       Impact factor: 2.279

4.  Moxibustion for the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis following PRISMA guidelines.

Authors:  Yumeng Tan; Jun Hu; Bing Pang; Lijuan Du; Yanan Yang; Qing Pang; Meizhen Zhang; Qian Wu; Yi Zhang; Qing Ni
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.